Preoperative risk stratification using gated myocardial perfusion studies in patients with cancer

Journal of Nuclear Medicine

Volumn 48, Issue 3, 2007, Pages 344-348

  Chang, Kiran ^a   Sarkiss, Mona ^a   Kyoung, Sook Won ^a,b   Swafford, Joseph ^a   Broemeling, Lyle ^a   Gayed, Isis W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Keimyung University School of Medicine   (South Korea)

Author keywords

Cancer; Myocardial perfusion imaging; Risk stratification

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL;

ARTICLE; CANCER PATIENT; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANK SUM TEST; RISK FACTOR; AGED; CORONARY ARTERY BLOOD FLOW; HEART MUSCLE ISCHEMIA; MIDDLE AGED; NEOPLASM; PATHOPHYSIOLOGY; RISK ASSESSMENT; SCAR; SCINTISCANNING;

AGED; AGED, 80 AND OVER; CICATRIX; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEOPLASMS; RISK ASSESSMENT;

EID: 34247209202     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cohen M, Curran P, L'ltalien G, et al. Long-term prognostic value of preoperative dipyridamole thallium imaging and clinical indexes in patients with diabetes mellitus undergoing peripheral vascular surgery. Am J Cardiol. 1999;83:1038-1042.
2. Harafuji K, Chikamori T, Kawaguchi S, et al. Value of pharmacologic stress myocardial perfusion imaging for preoperative risk stratification for aortic surgery. Circ J. 2005;69:558-563.
3. Chen T, Kuwabara Y, Tsutsui H, et al. The usefulness of dipyridamole thallium-201 single photon emission computed tomography for predicting perioperative cardiac events in patients undergoing non-cardiac vascular surgery. Ann Nucl Med. 2002;16:45-53.
4. Lette J, Waters D, Bernier H, et al. Preoperative and long-term cardiac risk assessment: predictive value of 23 clinical descriptors, 7 multivariate scoring systems, and quantitative dipyridamole imaging in 360 patients. Ann Surg. 1992;216:192-204.
5. Lette J, Waters D, Cerino M, et al. Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery. Am J Cardiol. 1992;69:1553-1558.
6. Devereaux P, Goldman L, Cook D, et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173:627-634.
7. Boucher CA, Brewster DC, Darling RC, et al. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med. 1985;312:389-394.
8. Fletcher JP, Antico VF, Gruenewald S, et al. Dipyridamole-thallium scan for screening of coronary artery disease prior to vascular surgery. J Cardiovasc Surg (Torino). 1988;29:666-669.
9. Lane SE, Lewis SM, Pippin JJ, et al. Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus. Am J Cardiol. 1989;64:1275-1279.
10. Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 1989;110:859-866.
11. Younis LT, Aguirre F, Byers S, et al. Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. Am Heart J. 1990;119:1287-1292.
12. Gupta P, Charan V, Kumar H. Cancer related thrombophilia: clinical importance and management strategies. J Assoc Physicians India. 2005;53:877-882.
13. Jain D. Cardiotoxicity of doxorubicin and other anthracycline derivatives. J Nucl Cardiol. 2000;7:53-62.
14. Nousiainen T, Jantunen E, Vanninen E, et al. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer. 2002;86:1697-1700.
15. Sobic-Saranovic D, Pavlovic S, Susnjar S, et al. Assessment of early epirubicin cardiotoxicity in women with breast cancer. Anticancer Res. 1997;17:3889-3891.
16. Prosnitz RG, Chen YH, Marks LB. Cardiac toxicity following thoracic radiation. Semin Oncol. 2005;32:S71-S80.
17. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet. 2000;355:1757-1770.
18. Cuzick K, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12:447-453.
19. Rutqvist LE, Lax I, Fornander T, et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int Radiat Oncol Biol Phys. 1992;22:887-896.
20. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 1992;69:1241-1247.
21. Almanaseer Y, Mukherjee D, Line-Rogers E, et al. Implementation of the ACC/AHA guidelines for preoperative cardiac risk assessment in a general medicine preoperative clinic: improving efficiency and preserving outcomes. Cardiology. 2005;103:24-29.
22. Eagle A, Berger B, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2002;94:1052-1064.
23. Falanga A. Thrombophilia in cancer. Semin Thromb Hemost. 2005;31:104-110.
24. Baron J, Gridly G, Weiderpass E, et al. Venous thromboembolism and cancer. Lancet. 1998;351:1077-1080.
25. Cestari D, Weine D, Panageas K, et al. Stroke in patients with cancer: incidence and etiology. Neurology. 2004;62:2025-2030.
26. Kertai M, Boersma E, Bax J, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart. 2003;89:1327-1334.
27. Mangano D, London M, Tubau J, et al. Dipyridamole thallium-201 scintigraphy as a preoperative screening test: a reexamination of its predictive potential - study of Perioperative Ischemia Research Group. Circulation. 1991;84:493-502.
28. Eagle K, Strauss H, Broucher C, et al. Dipyridamole-thallium scanning in patients undergoing vascular surgery: optimizing preoperative evaluation of cardiac risk. JAMA. 1987;257:2185-2189.
29. Boucher C, Brewster DC, Darling RC, et al. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med. 1985;312:389-394.
30. Brewster DC, Okada RD, Strauss HW, Abbott WM, Darling RC, Boucher CA. Selection of patients for preoperative coronary angiography: use of dipyridamole-stress-thallium myocardial imaging. J Vasc Surg. 1985;2:504-510.
31. Leppo J, Plaja J, Gionet M, et al. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol. 1987;9:269-276.
32. Pasternack P, Imparato A, Bear G, et al. The value of the radionuclide angiogram in the prediction of perioperative myocardial infarction in patients undergoing lower extremity revascularization procedures. Circulation. 1985;72:II13-II17.
33. Fiser W, Thompson B, Thompson R, et al. Nuclear cardiac ejection fraction and cardiac index in abdominal aortic surgery. Surgery. 1983;94:736-739.
34. Lette J, Waters D, Lassonde J, et al. Postoperative myocardial infarction and cardiac death: predictive value of dipyridamole-thallium imaging and five clinical scoring systems based on multifactorial analysis. Ann Surg. 1990;211:84-90.
35. Fleisher L, Rosenbaum SS, Stanely H, et al. Preoperative dipyridamole thallium imaging and ambulatory electrocardiographic monitoring as a predictor of perioperative cardiac events and long-term outcome. Anesthesiology. 1995;83:906-917.